Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,990 stories, page 631 of 750

Advanced search

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA set to review Sandoz's generic GLP-1s

ReutersOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Kubota Pharmaceutical Holdings Co. Ltd. – TSE:4596

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

WDEZOriginal source

🇺🇰Jun 29Regulatorygov.ukTier 1 · Regulatory source

Shiga toxin-producing Escherichia coli: how to avoid and treat

This guidance provides the sources of Shiga toxin-producing Escherichia coli (STEC) infection and gu...

UK Health Security AgencyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 29 June 2026

The Pharma LetterOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

US, Texas biotech firm to build 'Noah's Ark' for endangered species

AOL.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H – HKEX:2335

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion

The Manila TimesOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

EMA Recommends Approval of Hopledo for Parkinson's Disease

Intellectia AIOriginal source

🇺🇰Jun 29Regulatorygov.ukTier 1 · Regulatory source

DHSC evaluation strategy 2026

This evaluation strategy sets out the Department of Health and Social Care's (DHSC) vision for high-...

UK Department of Health and Social CareOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Samsung Bioepis announced on the 29th that it proved its equivalence with the original drug in each

매일경제Original source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

AbbVie Receives Positive CHMP Opinion for Upadacitinib for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Investing News NetworkOriginal source

🇺🇰Jun 29Regulatorygov.ukTier 1 · Regulatory source

Nearly 400 antibiotic-resistant infections each week in 2024

Antibiotic use within the NHS is below 2019 pre-pandemic levels but private prescribing increases.

UK Health Security AgencyOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

The U.S.-China biotech crackdown may hurt the scientists America needs the most

statnews.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Xerafy Smart RFID Label for Healthcare and Pharmaceutical Packagi

The National Law ReviewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More

RTTNewsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Seers wins FDA 510(k) for mobiCARE, speeds push into US Medicare market - CHOSUNBIZ

ChosunbizOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Telitacicept Improves Clinical Response but Increases Infection and Hypogammaglobulinemia Risk in Adults with Active SLE: Phase 3 Trial Results

Vera HealthOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biovitrum falls 3% after FDA declines approval for gout therapy By Investing.com

Investing.com AustraliaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biotech veterans aim to build startups from the ground up at CapeHaven

Hartford Business JournalOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

China closing in but US leads in biotech quality, commercial reach, survey finds

Post and CourierOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

AbbVie broadens immunology focus with $10.9 billion Apogee deal

Post and CourierOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Target trial emulation using French MS registry data replicated RCT treatment effects on relapse rate and EDSS progression, but not consistently on MRI outcomes, in patients with multiple sclerosis initiating disease-modifying therapies

Vera HealthOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

[BIO USA 2026] Galux pushes AI protein design toward bigger global pharma deals

koreabiomed.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Samsung Bioepis Demonstrates Equivalence in Phase 1 and 3 Trials of Keytruda Biosimilar

아시아경제Original source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab) – News Hub

Medianet News HubOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Vytrus Biotech SA – BME:VYT

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Swiss pharma at risk of US trade investigation, industry body says

ETPharma.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)

NTB KommunikasjonOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

The global push to reduce animal testing in drug development

Drug Target ReviewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Xerafy Smart RFID Label for Healthcare and Pharmaceutical Packaging to Be Featured by AIPIA at CPHI South East

EIN NewsOriginal source

🇺🇸Jun 29Industryinvestors.amneal.comTier 1 · Company source

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

Amneal Pharmaceuticals RSSOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Infigratinib Shows +2.1 cm/year Height Gain in Achondroplasia Trial

The Clinical Trial VanguardOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Shanghai MicuRx Pharmaceutical Co., Ltd. Class A Stocks

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Haisco Pharmaceutical Group Co. Ltd. Class A Actuals & Estimates (SZSE:002653)

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Kane Biotech Inc. – TSXV:KNE

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

LAST WEEK IN REVIEW

NAVLIN DAILYOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Lecanemab Alzheimer’s drug shows limited benefit, experts urge cautious use

동아사이언스Original source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

AriBio completes main phase 3 dosing for oral Alzheimer's drug AR1001, topline data due this fall

koreabiomed.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

GC Wellbeing secures Korean rights to next-gen fat-dissolving injection ahead of US phase 3 trial

koreabiomed.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response | Reports & Briefings | Jun 29, 2026

Information Technology and Innovation Foundation (ITIF)Original source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Inside Lilly's biotech startup factory

The Korea HeraldOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

SK chemicals, J2H Biotech sign LOI to co-develop MASH therapy

koreabiomed.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

How A Regional Pharmaceutical Leader Maintained Compliance Through Divestiture Without Disrupting Operations

Clinical LeaderOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Star Therapeutics to Present Complete Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease at ISTH 2026 Congress

BioSpaceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

INTERVIEW: Biotech Act rapporteur defends evidence-first approach to SPC debate

EuractivOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Binh Dinh Pharmaceutical & Medical Equipment JSC Stocks

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Autotelic Bio Wins FDA Approval for ATB-101 Phase 1 Trial in US

Seoul Economic DailyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

GC Wellbeing secures rights to next-gen fat-dissolving injection

The Korea HeraldOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

CSL halts Tavneos drug sale following EU regulatory setback

Capital BriefOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets

BioSpaceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Poland calls for unified EU strategy on biotech and critical medicines

EuractivOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

News | Biotech job, funding growth signal rising space demand; Mortgage applications increase; Construction employment slows

CoStarOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Ellagic Acid Market Forecast Points Higher Toward 2035, Driven by Pharmaceutical and Bioprocessing Demand

IndexBoxOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

AriBio Completes Patient Dosing in Global Phase 3 Trial of Oral Alzheimer's Drug

Seoul Economic DailyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Aribio Completes Global Phase 3 Trials for Oral Alzheimers Drug AR1001

Aju PressOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Kailera Appoints New Chief Corporate Affairs Officer

Intellectia AIOriginal source

🇺🇸Jun 29Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source